Učitavanje...
The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype
PURPOSE: The protein tyrosine phosphatase PTPN2 dephosphorylates several tyrosine kinases in cancer-related signalling pathways and is thought to be a tumour suppressor. As PTPN2 is not frequently studied in breast cancer, we aimed to explore the role of PTPN2 and the effects of its loss in breast c...
Spremljeno u:
| Izdano u: | J Cancer Res Clin Oncol |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Berlin Heidelberg
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6571101/ https://ncbi.nlm.nih.gov/pubmed/31025094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-019-02918-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|